RPL31P47

Across TCGA pan-cancer cohorts, RPL31P47 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL31P47 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPL31P47 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL31P47 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

UCS, KICH, and LUAD are the cancer types where RPL31P47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
LUAD	OS	Tertile	II,III,IV	0.528	0.677	<.001	45	view →
CESC	OS	Tertile	III,IV	0.068	0.756	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
HNSC	OS	Tertile	All	0.535	0.346	.016	24	view →
TGCT	OS	Tertile	All	0.534	0.968	<.001	18	view →
OV	OS	Tertile	All	0.899	0.824	.024	18	view →
COAD	OS	Tertile	III,IV	0.168	0.692	.043	9	view →
ESCA	OS	Quartile	All	0.583	0.738	.022	9	view →
STAD	OS	Tertile	III,IV	0.564	0.318	.030	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL31P47–UCS (DFS)

Open the UCS breakdown →